Cantor Fitzgerald, L. P. Sutro Biopharma, Inc. Transaction History
Cantor Fitzgerald, L. P.
- $90.6 Billion
- Q2 2025
A detailed history of Cantor Fitzgerald, L. P. transactions in Sutro Biopharma, Inc. stock. As of the latest transaction made, Cantor Fitzgerald, L. P. holds 500,000 shares of STRO stock, worth $575,000. This represents 0.0% of its overall portfolio holdings.
Number of Shares
500,000Holding current value
$575,000% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding STRO
# of Institutions
106Shares Held
59.1MCall Options Held
92.8KPut Options Held
0-
Black Rock Inc. New York, NY6.91MShares$7.95 Million0.0% of portfolio
-
Suvretta Capital Management, LLC New York, NY6.49MShares$7.46 Million0.16% of portfolio
-
Kynam Capital Management, LP Princeton, NJ5.09MShares$5.85 Million0.43% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.73MShares$5.44 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.12MShares$4.73 Million0.0% of portfolio
About SUTRO BIOPHARMA, INC.
- Ticker STRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,161,500
- Market Cap $60M
- Description
- Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...